Abstract
Patient-based questionnaires were designed with the aim to identify and rank long-term somatic and psychosocial morbidity in patients with low-stage testicular cancer. A further intention was to compare patients' assessments with experienced doctors' general opinion on quality of life items in cured testicular cancer patients. In pilot study I, 103 tumour-free patients ranked items of physical and psychosocial morbidity after having had various kinds of treatment. Though the ranking procedure appeared to cause some difficulties amongst the patients and subsequently was abandoned, the results indicated considerable differences between the patients' and doctors' evaluations. In pilot study II patients were asked to score the different items. The questionnaire of pilot study II was completed by 107 patients from the Norwegian Radium Hospital (NRH) and 99 relapse-free patients from the Royal Marsden Hospital (RMH) with testicular cancer stage I at least 1 year after infradiaphragmatic radiotherapy (n = 94) or adjuvant chemotherapy (2 cycles,n=26), or patients who had been followed on the surveillance program (n = 86). A total of 93 doctors completed a similar questionnaire, thereby expressing their general opinion on long-term morbidity in comparable testicular cancer patients as seen during routine clinical follow-up. Both the irradiated patients and those on the surveillance program reported slight degrees of Raynaud-like phenomena, neurotoxicity and ototoxicity, most probably representing “background morbidity” in an age-matched general male population. Doctors tended to underestimate their patients' somatic morbidity, but often overestimated the degree of psychological distress, in particular in patients on the surveillance program. Significant differences between RMH and NRH patients with regard to sexual problems and to leisure time activity may be explained by cultural differences in the two countries. The items presented in the questionnaire used identify important issues for patients cured of testicular cancer which may be used in future multicentre trans-cultural studies assessing these patients' quality of life. This will provide sufficient data for psychometric testing and, together with the findings from patients' free comments, support the final design of a testicular cancer quality of life module.
Similar content being viewed by others
References
Aaronson NK (1991) Methodological issues in assessing the quality of life of cancer patients. Cancer 67:844–850
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Fletcher H, Fleishman SB, Haes JCJM de, Kaasa S, Klee M, Osoba D, Razavi D, Role PB, Schraub S, Sneeuw K, Sullivan M, Takeda F, for the European Organization for Research and Treatment of Cancer Study Group on Quality of Life (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376
Bergman B, Sullivan M, Sörenson S (1992) Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile. Acta Oncol 31:19–28
Boyer M, Raghavan D (1992) Toxicity of treatment of germ cell tumors. Semin Oncol 19:128–142
Cassileth BR, Soloway MS, Vogelzang NJ, Chou JM, Schellhammer PD, Seidmon EJ, Kennealey GT. members of the Zoladex Prostate Cancer Study Group (1992) Quality of life and psychological status in stage D prostate cancer. Quality Life Res 1:323–330
Cullen MH, Cook J, Woodroffe C, Murphy A, Warwick J, Ferry D (1994) Surveillance or immediate adjuvant chemotherapy for stage I nonseminomatous germ cell tumours of the testis (NSGCTT). Br J Cancer 69 [Suppl 21]: 14
Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R (1993) Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation. Urology 149:237–243
Douchez J, Droz JP, Desclaux B, Allain Y, Fargeot P, Caty A, Charrot P (1993) Quality of life in long-term survivors of nonseminomatous germ cell testicular tumors. Urology 149:498–501
Fallowfield L (1990) The quality of life. The missing measurement in health care. Methodological issues. (Human horizon series) Souvenir Press, London, pp 43–44
Feldstein ML (1991) Quality-of-life-adjusted survival for comparing cancer treatments. A commentary on TWiST and Q-TWiST. Cancer 67:851–854
Fernandez C, Rosell R, Abad-Esteve A, Monras P, Moreno I, Serichol M, Roviralta M (1989) Quality of life during chemotherapy in non-small cell lung cancer patients. Acta Oncol 28:29–33
Finkelstein DM, Cassileth BR, Bonomi PD, et al (1988) A pilot study of the Functional Living Index-Cancer (FLIC). Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study. Am J Clin Oncol 11:630–633
Fossa SD, Aass N, Kaalhus O (1989) Radiotherapy for testicular seminoma stage I. Treatment results and longterm post-irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys 16:383–388
Fosså SD, Aaronson NK, Newling D, Cangh PJ van, Denis L, Kurth K-H, Pauw M de, members of the EORTC GU Group (1990) Subjective response to treatment of hormone-resistant metastatic prostatic cancer. Eur J Cancer Clin Oncol 26:1133–1136
Fosså SD, Jacobsen A-B, Aass N, Heilo A, Stenwig AE, Kummen O, Johannessen NB, Waaler G, Øgreid P, Borge L, Urnes T, Bjerklund-Johansen T (1994) How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited CT resources? Br J Cancer 74:652–658
Ganz PA, Haskell CM, Figlin RA, La Soto N, Siau J, for the UCLA Solid Tumor Group (1988) Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky Performance Status and the Functional Living Index-Cancer. Cancer 61:849–856
Haes JC de, Knippenberg FC van, Neut JP (1990) Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62:1034–1038
Kaasa S, Aass N, Mastekaasa A, Lund E, Fossa SD (1991) Psychosocial well-being in testicular cancer patients. Eur J Cancer 27:1091–1095
Kiebert GM, Haes JC de, Velde CJ van de (1991) The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients. A review. J Clin Oncol 9:1059–1070
Maunsell E, Brisson J, Deschênes L (1992) Psychological distress after initial treatment of breast cancer. Cancer 70:120–125
Moynihan C (1987) Testicular cancer: the psychosocial problems of patients and their relatives. Cancer Surv 6:477–510
O'Youg J, McPeek B (1987) Quality of life variables in surgical trials. J Chronic Dis 40:513–522
Parliament MB, Danjoux CE, Clayton T (1985) Is cancer treatment toxicity accurately reported? Int J Radiat Oncol Biol Phys 11:603–608
Parmar H, Phillips RH, Lightman SL, Edwards L (1988) How would you like to have an orchidectomy for advanced prostatic cancer? Am J Clin Oncol 11:160–168
Pont J, Höltl W, Kosak D, Machacek E, Kienzer H, Julcher H, Honetz N (1990) Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial. J Clin Oncol 8:16–20
Read G, Stenning SP, Cullen MH, Parkinson MC, Horwich A, Kaye SB, Cook PA, for the Medical Research Council Testicular Tumors Working Party (1992) Medical Research Council prospective study of surveillance for stage I testicular teratoma. J Clin Oncol 10:1762–1768
Rieker PP, Fitzegerald EM, Kalish LA (1990) Adaptive behavioral responses to potential infertility among survivors of testis cancer. J Clin Oncol 8:347–355
Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM (1988) Who should measure quality of life, the doctor or the patient? Br J Cancer 57:109–122
Smart CR, Yates JW (1987) Quality of life. Cancer 60:620–622
Sprangers MAG, Cull A, Bjordal K, Groenvold M, Aaronson NK, for the EORTC Study Group on Quality of Life (1993) The European Organization for Research and Treatment of Cancer approach to quality of life assessment: guidelines for developing questionnaire modules. Quality Life Res 2:287–295
Tannock IF, Gospodarowicz M, Meakin W, et al (1989) Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response. J Clin Oncol 7:590–597
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fosså, S.D., Moynihan, C. & Serbouti, S. Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage I. Support Care Cancer 4, 118–128 (1996). https://doi.org/10.1007/BF01845761
Issue Date:
DOI: https://doi.org/10.1007/BF01845761